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730Objectives: Achalasia has a variety of therapeutic options. We sought to determine the long-term outcome of
laparoscopic myotomy in a large group of patients.
Methods: We conducted a retrospective record review of 500 patients who underwent laparoscopic myotomy
and follow-up with a standardized dysphagia questionnaire.
Results: Between April 1998 and June 2011, 276 men and 224 women underwent a laparoscopic myotomy.
Their median age was 51 years (range, 8-89 years). Preoperative symptoms included dysphagia in 472 patients
(94.4%), regurgitation in 382 patients (76.4%), heartburn in 203 patients (40.6%), chest pain in 168 (33.6%)
patients, and weight loss (median, 10 kg) in 264 patients (52.8%). Prior therapy (dilation in 239, botulinum toxin
type A in 135, or myotomy in 30) had been performed in 303 patients (60.6%). Preoperative manometry was
available in 413 patients (82.6%) and revealed a median lower esophageal sphincter pressure of 31 mm Hg
(range, 0-50 mm Hg), absent peristalsis in 97.6%, and no lower esophageal sphincter relaxation in 75.1%.
A laparoscopic myotomy with partial fundoplication (Toupet n ¼ 268, Dor n ¼ 209) was done in 477 patients
(95.4%) and myotomy only in 23 patients (4.6%). Conversion to open was necessary in 16 patients (3.2%).
There were 52 (10.4%) esophageal perforations—all repaired during the myotomy—and 26 (5.2%) other
complications, including bleeding, atrial fibrillation, and pneumonia. There was no operative mortality.
Median length of stay was 2 days (range, 1-20 days). Dysphagia questionnaires were returned by 48.2% of
patients (241 out of 500) a median of 77.5 months after myotomy (range, 15-176 months). Eighty patients
(32.2%) reported no problems with swallowing at the time of the survey. Of 160 patients who had swallowing
problems, 40 patients (22.2%) classified the problem as mild or less, 98 patients classified the problem as
moderate (70.0%), and 22 patients classified the problem as severe (15.7%). The question concerning frequency
of swallowing problems was answered by 160 patients and occurred once a week or less in 70 patients (43.8%),
several times aweek in 41 patients (25.6%), and at least daily in 49 patients (30.6%). Analysis of all 241 patients
who returned questionnaires revealed that 170 out of 241 (70.5%) reported heartburn, 89 out of 241 (36.9%)
reported regurgitation, and 159 out of 241 (66.0%) had taken antacids or histamine 2 blockers or proton
pump inhibitors within the past 30 days of the survey. The only factor affecting outcome was age; patients older
than age 65 years had a better chance of having no difficulty swallowing at follow-up (P ¼ .0174). Sex, prior
therapy, Toupet versus Dor, conversion to open, or esophageal mucosal perforation did not affect long-term
swallowing outcome.
Conclusions: Laparoscopic myotomy with partial fundoplication is a safe operation. The long-term outcome
is extremely effective and approximately one-third of patients have no evidence of persistent symptoms at
follow-up. Furthermore, those who have persistent symptoms rarely have severe or very frequent complaints.
Patients older than age 65 years tend to have a better outcome. (J Thorac Cardiovasc Surg 2014;147:730-7)Achalasia is a disease characterized by failure of the
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The Journal of Thoracic and Cardiovascular Surgesophageal peristalsis. The classic treatment is to
render the LES incompetent to relieve the obstructive
symptoms and prevent massive esophageal dilation.
Destruction of the LES can lead to significant symptoms
from reflux esophagitis. Laparoscopic techniques are
now used to perform a surgical myotomy and perform
a partial fundoplication to treat patients with achalasia.
We have employed this technique since the mid-1990s
as the main surgical therapeutic intervention in patients
with achalasia. We sought to examine the long-term
outcome of the procedure by using a standardized
30-day dysphagia questionnaire on patients who have
undergone laparoscopic treatment for achalasia at our
institution.ery c February 2014
Abbreviations and Acronyms
H2 ¼ histamine 2
LES ¼ lower esophageal sphincter
PPI ¼ proton pump inhibitor
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Mayo Foundation Institutional Review Board approved this study. All
patients who underwent surgical treatment for achalasia at the Mayo Clinic
in Rochester, Minnesota, between April 1998 and June 2011 were
reviewed. Eligible patients included those with a diagnosis of achalasia
who underwent an attempted laparoscopic myotomy with or without a
fundoplication. Patients who underwent a thoracotomy for a longmyotomy
or underwent an esophagectomy for achalasia were excluded. Medical
records were reviewed for demographic information, medical history,
radiographic findings, surgical approach, and procedural and postoperative
complications. A standardized 30-day dysphagia questionnaire was sent to
all patients during the follow-up period.1 Postoperative complications
included those that occurred within 30 days of the procedure or during
the same hospitalization. Similarly, operative mortality included patients
who died within the first 30 days after surgery or during the same hospital
admission. Factors affecting functional results were analyzed by univariate
andmultivariate analysis. Descriptive statistics for categorical variables are
reported as frequency and percentage, and continuous variables are
reported as mean  standard deviation or median (range), as appropriate.
All statistical tests were 2-sided.G
T
SRESULTS
There were 500 patients—276 men and 224 women—
who underwent surgical myotomy for achalasia during the
study period (Table 1). The median age was 51 years
(range, 8-89 years). Preoperative symptoms were present
in 472 patients (94.4%). Weight loss before the surgical
procedure had occurred in 264 patients (52.8%). Median
weight loss was 10 kg (range, 1-80 kg).
Preoperative esophageal motility data was available in
413 patients (82.6%) and showed no peristalsis in 403
patients and only minimal contractions in 10 patients.
LES pressure measurements were available in 367 patients.
The median LES was 31 mmHg (range, 4-150 mmHg) and
was>25 mm Hg in 233 patients. There was data on LES
relaxation in 412 patients; 320 patients showed no LES
relaxation and 93 had some. Prior interventional therapy
had been performed in 303 of patients (60.6%). The
interventions included dilations in 239 patients (47.8%),
botulinum toxin type A injections in 135 patients
(27.0%), and prior myotomy in 30 patients (6.0%). The
30 prior myotomies were performed a median of 4.7 years
before (range, 3.8 months-50 years). The reoperation was
a laparoscopic myotomy with Toupet fundoplication in
4 patients, with Dor fundoplication in 9 patients, and with
no fundoplication in 18 patients. Only 2 of these patients
required conversion to an open procedure.
The operative procedure was laparoscopic myotomy
with Toupet fundoplication in 268 patients (53.6%),
laparoscopic myotomy with Dor fundoplication in 209The Journal of Thoracic and Capatients (41.8%), and laparoscopic myotomy only in 23
patients (4.6%). The choice of a Dor or Toupet fundoplica-
tion was based on surgeon’s choice. The myotomy typically
went as high as possible using a laparoscopic approach
(typically above the inferior pulmonary vein) and was
carried onto the stomach for 2 cm. Conversion to an open
procedure was necessary in 16 patients (3.2%). Reasons
for conversion were to repair a breach of the esophageal
mucosa in 7 patients, to control bleeding in 4 patients,
intra-abdominal adhesions in 3 patients, and inability to
find the correct myotomy plane in 2 patients. The rate of
conversion did not vary significantly during the 14 years
of the study and ranged from 1 to 3 conversions per year.
The median length of stay after surgery was 2 days
(range, 1-20 days); 374 patients (74.8%) stayed 2 days or
fewer. Median length of stay for patients that required an
open procedure was 5 days (range, 3-10 days). There were
no operative mortalities. Complications occurred in
18 patients (3.6%) and included urinary retention in
4 patients; ileus in 3 patients; atrial fibrillation in 3 patients;
bowel perforation requiring subsequent surgery in 2 patients
(1 was from a esophageal perforation at the time of
myotomy that subsequently leaked and was repaired with
a Belsey procedure, the other was from a unrecognized
small bowel perforation created while taking down
adhesions); pneumonia in 2 patients; and urinary infection,
respiratory failure, diarrhea, leg cellulitis, herpes zoster, and
esophageal obstruction from diaphragmatic constriction
requiring reoperation in 1 patient each. The overall rate of
esophageal perforation at the time of myotomy was
10.4% (52 out of 500 patients) and was affected by prior
therapy. Of the 30 patients that had undergone a prior
myotomy and 7 patients (23.3%) had a mucosal perforation
at the time of redo laparoscopic myotomy; however, having
a dilation or botulinum toxin type A injection did not signi-
ficantly affect the rate of esophageal perforation at the time
of laparoscopic myotomy (11.7% and 10.4%, respectfully).
Dysphagia questionnaires were sent to all 500 patients;
241 (48%) returned a completed survey. There was no
response from the survey from 164 patients (33%), the
survey was returned unopened from 64 patients (13%),
notification of the patient’s death occurred in 10 patients
(2%), and 21 patients (4%) declined to participate in the
survey. There was no statistically significant difference in
the median age or sex of patients who returned the survey
and those who did not; however, there was a difference in
the median time from surgery to the return of the survey
in those who responded to the survey and those who did
not respond (6.4 years between surgery and the survey for
responders vs 7.4 years for nonresponders; P ¼ .0033).
Completed surveys were returned a median of 77.5 months
after surgery (range, 15 months-14.7 years).
There were 80 out of 241 patients (33.2%) who reported
they had no swallowing problems on the follow-uprdiovascular Surgery c Volume 147, Number 2 731
TABLE 1. Demographic and clinical data of patients who underwent
laparoscopic myotomy
Variable
Overall
(N ¼ 500)
Answered
questionnaire
(n ¼ 241; 48.2%)
Did not answer
questionnaire
(n ¼ 259; 51.8%)
Age, y (median
[range])
51 (8-89) 53 (11-88) 48 (8-89)
Sex, n
Men 276 (55) 137 (56.8) 139 (53.7)
Women 224 (45) 104 (43.2) 120 (46.3)
Symptoms
Dysphagia
Solids 295 (59) 144 (59.8) 151 (58.3)
Liquids 19 (3.8) 9 (3.7) 10 (3.9)
Solids and liquids 158 (31.6) 74 (30.7) 84 (32.4)
Regurgitation 382 (76.4) 179 (74.3) 203 (78.4)
Heartburn 203 (40.6) 102 (42.3) 101 (39.0)
Chest pain 168 (33.6) 83 (34.4) 85 (32.8)
Manometry 413 (82.6) 186 (77.2) 227 (87.6)
Absent peristalsis 403 (80.6) 225 (93.4) 178 (68.7)
LES pressure,
mm Hg (median
[range])
31 (4-150) 34 (4-150) 31 (6-116)
Absent LES
relaxation
320 (64.0) 160 (66.4) 160 (61.8)
Prior therapy 303 (60.6) 144 (59.8) 159 (61.4)
Dilation 239 (47.8) 111 (46.1) 128 (49.4)
botulinum toxin
type A injection
135 (27.0) 59 (24.5) 76 (29.3)
Surgical myotomy 30 (6.0) 15 (6.2) 15 (5.8)
Values are presented as number (%) unless otherwise specified. LES, Lower
esophageal sphincter.
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Sdysphagia questionnaire. Of 161 patients (66.8%) who
reported problems swallowing, when asked to rate the
severity of their swallowing difficulty over the past
30 days, 9 patients (5.7%) responded that it did not botherFIGURE 1. Rating of severity of swallowin
732 The Journal of Thoracic and Cardiovascular Surgthem at all, 29 (18.4%) described it as mild, or ‘‘can be
ignored if I don’t think about it,’’ 98 (62.0%) described it
as moderate, ‘‘cannot be ignored, but does not affect my
lifestyle,’’ 17 (10.8%) described it as severe, ‘‘affects my
lifestyle,’’ and 5 (3.2%) described it as very severe,
‘‘markedly affects my lifestyle.’’ Three patients did not
answer the question. Patients were asked to rate their
swallowing trouble on a scale of 1 (not severe at all) to 10
(very severe). The median response was 4 (range, 1-10)
(Figure 1). When asked how often they had difficulty
swallowing in the past 30 days, 68 (43%) answered once
a week or less, 41 (26%) answered several times a week,
24 (15%) answered daily, and 25 (16%) answered with
each meal. Of those with swallowing problems, 50 patients
(31.3%) had difficulty with liquids and 149 patients
(93.1%) had difficulty with solid food. The types of
solid food that patients had difficulty with are shown in
Table 2.
There were 98 patients who had follow-up of 5 years or
less and 37 patients (46.3%) had no trouble swallowing.
Of the 61 who had swallowing difficulty and followed for
5 years or fewer, only 7 (7.1%) patients had a severity
>5. There were 143 followed for>5 years; 43 (53.8%)
had no trouble swallowing; however, in this group with
longer follow-up there were 30 (16.1%) who stated their
severity of swallowing difficulty was>5 (Figure 2). Neither
of these differences was statistically significant (P ¼ .23
and .22, respectively).
There were 113 patients who had all 3 classic findings on
manometry for achalasia: LES>20 mm Hg, no peristalsis,
and no LES relaxation. In this group 41 patients (36.3%)
had no difficulty swallowing at follow-up, but there were
19 patients (16.8%) who rated their swallowing difficulty
>5. There were 77 patients who had at least 1 of the classic
manometric findings missing from their preoperativeg difficulty after laparoscopic myotomy.
ery c February 2014
TABLE 2. Patients that had trouble swallowing foods
Type of food n %
Oatmeal (or other foods, like grits, cream of wheat, or rice) 21 13.3
Banana (or other foods, like pudding or gelatin dessert) 26 16.5
Apple (or other foods with fiber, such as celery) 80 50.6
Ground meat (like hamburger or ground turkey) 71 44.7
Bread (or other foods, like cake, donuts, or muffins) 114 71.7
Meat (fibrous meats, like steak or chicken) 110 68.8
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swallowing difficulty at follow-up, but there were only
5 (6.5%) who rated their swallowing difficulty
>5 (Figure 3). Neither of these differences was statistically
significant (P ¼ .47 and .95, respectively).
Of 30 patients (6.0%) who had undergone a prior
myotomy, 15 (50%) returned the questionnaire. Only
2 patients (13.3%) had no swallowing problems at
follow-up. On a severity scale of 1 to 10 patients who had
swallowing problems reported that the severity was a
median of 5 (range, 2-8). When asked how often they had
difficulty swallowing in the past 30 days, 60% stated they
had difficulty at least once a week.
Among patients who responded to the questionnaire, 170
(70.5%) said they had experienced heartburn during the
past 30 days. Of those that experienced heartburn in the
past 30 days, it occurred once a month or less in 41%, about
once a week in 32%, and several times a week or daily in
28%. Regurgitation occurred in 89 patients (36.9%) but
only 30 (33.7%) of these complained of regurgitation at
least once a week. There were 159 survey responders
(66.0%) who were taking antacids, histamine 2 receptor
(H2) blockers, or proton pump inhibitors (PPIs) at follow-
up (antacids, 114 [47.3%]; H2 blockers, 38 [15.8%]; and
PPIs, 96 [39.8%]). There were 23 patients who had
myotomy only, without fundoplication. Eleven of these 23
patients returned a questionnaire and 9 patients (81.8%)
still had dysphagia and 7 patients (63.6%) had reflux
symptoms, 5 of them at least weekly.FIGURE 2. Rating of severity of swallowing d
The Journal of Thoracic and CaFactors affecting whether or not patients stated they had
any swallowing problems or not during the past 30 days at
follow-up were examined. Only age65 years affected this
outcome variable. For patients aged 65 years or older, the
odds ratio (OR) was 2.1 (95% confidence interval [CI],
1.10-4.02; P ¼ .0252) for this older group to state they
did not have any swallowing problems in the past 30
days. Other factors, including sex, previous dilation,
botulinum toxin type A injection, or myotomy, Toupet
versus Dor, conversion to open procedure, and esophageal
perforation did not affect the outcome. Similarly, patients
aged 65 years and older were less likely to experience
heartburn or regurgitation after a myotomy (OR, 2.30;
95% CI, 1.18-4.48; P ¼ .0146). Sex, prior dilation,
botulinum toxin type A, or myotomy, Toupet versus Dor,
conversion to open lobectomy, and esophageal perforation
did not affect whether or not patients experienced heartburn
or regurgitation at follow-up. We did find that women were
less likely than men to be taking antacids, H2 blockers, or
PPIs at follow-up but this was not statistically significant
(OR, 0.52; 95%CI, 0.30-0.91; P¼ .02). Age, prior dilation,
botulinum toxin type A, or myotomy, Toupet versus Dor,
conversion to open lobectomy, and esophageal perforation
did not affect whether or not patients were taking antacids,
H2 blockers, or PPIs at follow-up.DISCUSSION
Achalasia has a variety of treatment options, including
endoscopic injection of botulinum toxin type A, balloon
dilation, and surgical myotomy. In this review of our
experience with laparoscopic myotomy for achalasia, we
tried to examine the long-term outcome of the procedure.
By using a standardized questionnaire we found that
the therapy is extremely effective and approximately
one-third of patients have no esophageal symptoms at
follow-up. In patients who did have symptoms they were
relatively infrequent.ifficulty according to length of follow-up.
rdiovascular Surgery c Volume 147, Number 2 733
FIGURE 3. Rating of severity of swallowing difficulty according to whether or not all achalasia motility criteria were present on preoperative
motility study.
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SSurgical esophageal myotomy can be accomplished via
the chest or abdomen and via an open or minimally
invasive thoracoscopic or laparoscopic approach. Although
endoscopic pneumatic dilation of LES is the most effective
nonsurgical treatment for achalasia, review of patients who
underwent surgical myotomy has established surgical
myotomy as safe procedure with a superior rate of symptom
improvement.2 Kostic and colleagues3 reported a random-
ized controlled trial where patients underwent either
pneumatic dilation or laparoscopic myotomy. Although
only a small number of patients were included in each
arm (pneumatic dilation in 26 patients and laparoscopic
myotomy in 25 patients), the results showed surgery
resulted in better symptom relief and reduced failure rate
at 12 months.
In this analysis of our patients we tried to determine the
long-term outcome of laparoscopic myotomy. Our median
follow-up is almost 6.5 years and like our report on the
short-term outcome (5.3 months), the results were quite
good.4 Almost one-third of patients reported no swallowing
problems at all on the follow-up questionnaire and of the
remaining that did have trouble, 85%were less than severe,
and almost half had problems only once a week or less.
Thus, laparoscopic myotomy when combined with a partial
fundoplication seems to be an effective and long-lasting
treatment for achalasia. There probably is some deteriora-
tion of the efficacy of the myotomy because our results
are a bit worse for those with longer follow-up.
Others have found similar outcomes. Weber and
colleagues5 looked at patients who had a laparoscopic
myotomy or pneumatic dilation with at least 5 years of
follow-up. They identified 36 studies between 2001 and
2011 and found that for pneumatic dilation, the mean
5-year remission rate was 61.9% and the mean 10-year
remission rate was 47.9%. The mean 5- and 10-year734 The Journal of Thoracic and Cardiovascular Surgremission rates after laparoscopic myotomy were much
better at 76.1% and 79.6%, respectively. They concluded
that laparoscopic myotomy affords greater long-term
durability.
The report by Boeckxstaens and colleagues6 states that
results of laparoscopic myotomy are not superior to
pneumatic dilation. Our findings do not directly compare
the 2 therapeutic modalities, but our follow-up is
considerably longer at a median of 6.4 years. As discussed
by Patti and Pellegrini,7 in the United States most patients
are now treated with laparoscopic myotomy with excellent
outcomes. We agree with Patti and Pellegrini7 that
pneumatic dilation should be used for patients that are unfit
for definitive laparoscopic surgery.
Patients who present for myotomy without all 3 of the
classic manometric findings on preoperative manometry
testing pose a difficult management problem. We have
shown that even in patients without all the so-called classic
findings, results are still good with 30% having no
problems swallowing and only 6.5% having more severe
difficulty at follow-up. It would seem from this data that
recommendation of a surgical myotomy is reasonable in
patients thought to have achalasia but do not have all 3 of
the classic findings on manometry.
Although it is agreed that addition of fundoplication to
laparoscopic myotomy decreases gastroesophageal reflux
symptoms and acid exposure, there is far less consensus
on the type of fundoplication. Most surgeons agree upon a
partial fundoplication because a full fundoplication would
lead to a high incidence of dysphagia in patients without
esophageal peristalsis. We used either an anterior
(ie, Dor) or posterior (ie, Toupet) fundoplication in our
patients and were not able to detect a difference in the
outcome between the 2 techniques. Rawlings and
colleagues8 also saw this finding of equality between theery c February 2014
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trial of the 2 techniques. They carefully studied patients
after laparoscopic myotomy with Toupet or Dor
fundoplication and found no statistical difference in the
dysphagia or regurgitation symptoms. The choice of which
technique of fundoplication to use seems to be best left to
the surgeon.
A small number of patients (4.6%) in our series had a
myotomy without an antireflux procedure. More than
80% of these were performed in the early stages of this
series, before the inclusion of an antireflux procedure was
appreciated. As noted in the results, these patients were
more likely to have reflux symptoms and their symptoms
were more frequent. We currently recommend the inclusion
of a partial fundoplication for patients undergoing a
laparoscopic myotomy.
Esophageal mucosal disruptions occurred in 52 patients
(10.4%) in our series and all of them were identified
intraoperatively and repaired. Rate of intraoperative
esophageal perforation during laparoscopic myotomy varies
from 0% to 33% in several series.2,4,9-17 Only 1 patient had
a delayed presentation of a mucosal perforation and
required a subsequent operation to repair the leak. When
mucosal perforations do occur, our current treatment
recommendation is that they should be repaired
laparoscopically with fine sutures with the addition of a
Dor-type fundoplication to buttress the repair. Other than a
prior myotomy, prior therapy—such as dilation or
botulinum toxin type A—did not seem to affect the rate of
esophageal perforation at the time of myotomy. However,
nonsurgical procedures, such as dilation or botulinum toxin
type A, should not be done as a trial to see if they help, unless
the diagnosis is in doubt or thepatient is true too ill to undergo
surgery. As stated above these nonsurgical therapies are not
as effective in the long-term management of achalasia.
The operative morbidity was 3.6% in our series.
Complications in several other series vary from 0 to
16%.9,17 The overall complication rate in the review by
Campos and colleagues2 was 6.3%. Most complications
in our series were of minor nature except 2 patients
who had bowel perforation and needed subsequent
surgery. Similarly, operative mortality has traditionally
been low or nonexistent in series involving laparo-
scopic myotomy.4,9,14,16,17 These results of minimal
operative mortality and morbidity reiterate the fact that
laparoscopic myotomy is safe.1,18
The questionnaire used, the Mayo Dysphagia
Questionnaire-30, offers a focused, validated tool for
patients with benign esophageal diseases. The Mayo
Dysphagia Questionnaire-30 records a patient’s dysphagia
symptoms at a specific time. The primary use is to assess
the frequency and severity of dysphagia and other
factors that affect swallowing symptoms. The
reliability and concurrent validity of the Mayo DysphagiaThe Journal of Thoracic and CaQuestionnaire-30 has been established from earlier
studies.1,18 In our study, we only queried patients at
1 point in time; thus, we may have miscategorized
patients with varying symptomatology.
Only 49% of living patients returned the survey and
those who did were closer to their surgical date than the
nonresponders (6.4 vs 7.4 years). We hypothesis that the
nonresponders may have been less likely to respond
because they had become used to any residual symptoms
and may have been tired of answering questions about their
disease. The long length of the questionnaire (7 pages) may
have significantly decreased the response rate. Overall the
average response rate of mailed questionnaires from
physicians is about 60%.19 We did try to increase our
response rate by sending a second mailing to those that
did not initially respond and all questionnaires included a
return-stamped envelope. If the response rate leads to bias
in the outcome is uncertain.
As we demonstrated in our early report, patients who un-
dergo a redomyotomyhave aworse outcomewhencompared
with patients undergoing an initial myotomy.4 The reasons
for this are unclear, but certainly scar tissue and selection
bias play a role.We found a similarworse outcome in patients
undergoing a redo operation in this series.
Patients older than age 65 years had less likelihood of
swallowing problems, heartburn, or regurgitation at the
time of follow-up. Roll and colleagues20 found similar
findings in older patients who underwent laparoscopic
myotomy. They found that older patients had better relief
of dysphagia, less heartburn, and less chest pain. Also, older
patients required less postoperative dilations or additional
surgery for recurrent or persistent symptoms. Based on their
review, they suggested laparoscopic myotomy as first-line
therapy for older patients. Similarly, Gockel and
colleagues21 found favorable results for patients older
than age 40 years and comparable to younger patients.
Although the symptomatic improvement after surgical
myotomy is well known in the short- and midterm, our
study focused more on the long-term functional outcome
after laparoscopic myotomy. At a median follow-up of 77
months we found that a laparoscopic myotomy with partial
fundoplication is a durable therapy for patients with
achalasia. Older patients tend to have better outcomes at
follow-up and should be offered surgical therapy.
CONCLUSIONS
Laparoscopic myotomy with partial fundoplication is a
safe operation. The long-term outcome is extremely
effective and approximately one-third of patients who
responded to our questionnaire have no evidence of
persistent symptoms at follow-up. Furthermore, those who
have persistent symptoms rarely have severe or very
frequent complaints. Patients older than age 65 years tend
to have a better outcome.rdiovascular Surgery c Volume 147, Number 2 735
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Dr Bryan F. Meyers (St Louis, Mo). Congratulations on your
presentation. This is a big study with consistent techniques. You
have excellent clinical work and no deaths out of 500 patients,
not even a rare pulmonary embolism or some other freak
complication. It was near-perfect initial results. You had only 1
late leak at the myotomy site, which is excellent. I commend
you on the notion of intent to use a standardized technique to
measure a subjective outcome that can be very difficult to pin
down.
I do have to mention a few criticisms. There is no preoperative
use of the Mayo Dysphagia Questionnaire-30. Your tool was not
used preoperatively, so it limits your ability to show an
improvement or the degree of improvement in any of the patients
or look for associations between preoperative factors and the
degree of improvement. There is no discussion of additional
surgery over the course of their recovery. So a redo myotomy,
subsequent esophagectomy, or the occasional hiatal hernia that
happens after a Dor are not addressed. What role they played on
patients’ quality of life are not touched, and to that extent it doesn’t
really predict the experience or outcome of the patients. You have
missing data in 50% of patients, and what happened to the missing
patients could really dictate the overall group when half didn’t
return the questionnaires.
I have 3 very brief and focused questions. Did you use the same
validated tool throughout? Your first patient was in 1998, but the 2
references on the tool were in 2007 and 2010, and so there is a big
lag time there.
Dr Krishnamohan. The same questionnaire was used for all
patients in the study.
Dr Meyers. With the missing data, can you really infer that
older patients do better? You didn’t really assess them before,
and I could give you several plausible explanations why they
have fewer complaints later: they have other medical problems
that trump their swallowing or they have poor memory, so they
can’t remember 30 days ago when they choked on steak.
Can you give me a biologic explanation of why they would do
better?
Dr Krishnamohan. I appreciate that point. It would be good if
we had a questionnaire assessment at several points of time for
those patients or another timed barium swallow to add additional
information. This questionnaire has been validated in other studies
to assess benign esophageal symptoms, and we expect that patients
who answer within the 30 days should be reflective, but there could
be a bias. Other studies have shown that the average response rate
for any questionnaire sent by a physician averages around 60%,
and our response rate was 48%. We tried to improve the response
rate by sending a second questionnaire, but the best response we
could get was 48%.
Dr Meyers. I know it is a challenge, but it’s hard to know what
to do when half the patients don’t respond. Half could be wind-
surfing in Florida or half might be in a nursing home aspirating.
We just don’t know what is going on with them. We hope the
ones you got are representative of all of them, but, to a large extent,
we don’t know. Anyway, this is excellent, qualitative work that
helps generate hypotheses and maybe lays a foundation for future
work, but it is hard to come upwith a solid change in practice based
on qualitative work with half the patients not responding.ery c February 2014
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SDr Krishnamohan. Thank you for your remarks. When we
looked at the patients who responded versus those who did not
respond, the only difference between the 2 groups we could find
was the length of follow-up. Patients who responded—the
median—they were 6.5 years from surgery, when those who did
not respond were farther out from surgery—7.5 years—and the
difference was significant, but other parameters were not different
between the 2 groups.
Dr Mark K. Ferguson (Chicago, Ill). I enjoyed your
presentation, thank you.
I have 2 pretty simple questions. First, in my practice we rarely
use manometry to make the diagnosis of achalasia. It is pretty
simple to make a clinical diagnosis with a barium swallow and
then rule out other problems with endoscopy. I’m wondering
how your institution uses the information from manometry to
either select patients for surgery or tailor the operation differently
than it might be done in a routine fashion.
Dr Krishnamohan. The manometry helps to confirm the
diagnosis and occasionally will lead us to perform a different
type of operation.
Dr Ferguson. The second question is about the terminology
used in your questionnaire. You speak in your presentation about
swallowing difficulty. I’m not sure if that is the exact terminology
that is used in the questionnaire. When I ask patients about
difficulty swallowing, at least a third of them will say, ‘‘No,
I have no problems swallowing, but then the food sticks down
here afterward.’’ So when I ask the question, it doesn’t really get
at the severity of symptoms that they are having from achalasia.
Dr Krishnamohan. The questionnaire has 28 questions
and many subquestions. It includes symptoms about heartburn
and regurgitation, including the severity and frequency.
The questionnaire is a very complete assessment.
Dr Ferguson. So you are speaking of swallowing difficulty as a
composite score of a complex questionnaire.
Dr Krishnamohan. Yes, we tried to report the results of the
questionnaire to reflect the overall outcome.
Dr Ferguson. Thank you.
Dr Steven R. DeMeester (Los Angeles, Calif). Congratulations
on a large series and a nice presentation.
One of the long-term problems with treatment of achalasia is
reflux disease and the complications of reflux disease on an
aperistaltic esophagus. I was struck by the fact that 70% of your
patients had trouble swallowing and 70% also had heartburn or
reflux symptoms. Do you have an idea if the difficulty with
swallowing was a complication of reflux or was this an incomplete
myotomy? And the reflux really needs to be explored. That’s one
of the concerns we have with the per-oral endoscopic myotomy
procedure— we’re not adding an antireflux procedure to it—and
long term what are the implications of that? I encourage you to
really look at that reflux and assess how severe the reflux disease
was and if there were strictures from reflux that caused the trouble
swallowing.The Journal of Thoracic and CaDr Krishnamohan. We performed a partial fundoplication as
routine for most patients. The set of patients who did not have a
fundoplication were earlier on in the series when the importance
of fundoplication was not really established and it was
controversial. There have been other studies that show that the
swallowing disorder after a fundoplication is comparable to those
patients who did not have a fundoplication, but the incidence of
pathologic and clinical gastroesophageal reflux is lower if there
is a fundoplication with a myotomy.
Dr Thomas Rice (Cleveland, Ohio). I have some comments.
Achalasia is a neurodestructive, lifelong disease, so I object to a
long-term follow-up of 28 days. I think it is very, very short early
postoperative follow-up that you have done. Also, in your
definition of achalasia, and the requirement of a hypertensive
lower esophageal sphincter is very, very uncommon. Fewer than
one-third of people have it. As well, you defined a hypertensive
lower esophageal sphincter as>24 mm Hg, but normal resting
pressure is up to 40 mm Hg. Depending upon the manometry,
that is considered normal.
Just a few comments and about manometry. Achalasia is a
manometrically defined disease, so it is required in all
patients and I would strive to do high-resolution manometry
in all patients so that they have best diagnostic and follow-up
studies.
There is a big disconnect between symptoms, function, and
morphology, and, really, to do a timed barium esophagram
and high-resolution manometry postoperatively would be helpful
and supplement the symptom score.
Dr Tomasz Grodzki (Szczecin, Poland). I have a short
question. The major complaint of the patients was lack of
peristalsis. Did you give them any medication to improve it?
The results that one-third of patients improved does not sound so
optimistic. You did a physical job in experienced hands and the
improvement was not so satisfactory. Did you try any complex
therapy, or it was just surgery and nothing more?
DrKrishnamohan. I think you have misunderstood our results.
We showed that one-third of patients had no symptoms at all, no
problems swallowing, and those who had some residual symptoms
for the most part had only mild symptoms.
Dr Frank D’Ovidio (New York, NY). Congratulations on your
nice presentation.
If you were able to subgroup patients according to type of
achalasia—for example, patients with preserved body of the
esophagus, those with mega esophagus, those with a sigmoid
esophagus, and also patients with spastic achalasia—would these
different forms of achalasia have different preoperative and
postoperative presentations and also long-term results?
DrKrishnamohan.We did not try to differential patients based
on those subgroups. We reviewed retrospectively all patients who
underwent a myotomy. I’m sure this group of 500 did have all
those types of achalasia but we did not attempt to subclassify those
patients or study the results.rdiovascular Surgery c Volume 147, Number 2 737
